Reversal of MDS and cytogenetic abnormalities after HSCT
Patient no. . | Time point, y . | Pretransplantation BM . | Posttransplantation BM . | ||||
---|---|---|---|---|---|---|---|
Cellularity, % . | BM content . | Cytogenetics . | Cellularity, % . | BM content . | Cytogenetics . | ||
1 | 2 | 40-60 | Atypical megakaryocytes, 10%-15% plasma cells | Normal | 40-60 | Trilineage hematopoiesis, 8%-10% plasma cells | Normal |
2 | 0.2 | 50 | ↑Megakaryocytes, Dysplasia, ? clonal LGL | ND | 30 | ↓ Megakaryocytes, hemophagocytic macrophages | ND |
3 | 0.6 | 5-20 | Markedly hypocellular with trilineage hypoplasia | −Y | 60 | Normal marrow | Normal |
4 | 0.6 | 30-60 | ↓ Atypical megakaryocytes, focal ↑ blasts | +8 | 40-50 | Trilineage hematopoiesis | Normal |
5 | 1.0 | 50-60 | Atypical megakaryocytes, 10% myeloblasts | −6 | 10-60 | Few atypical megakaryocytes, < 5% blasts | Normal |
6 | 0.6 | 40-60 | Atypical megakaryocytes, mild dysplasia | −7 | 10-20 | Trilineage hypoplasia, no ↑ blasts | Normal |
Patient no. . | Time point, y . | Pretransplantation BM . | Posttransplantation BM . | ||||
---|---|---|---|---|---|---|---|
Cellularity, % . | BM content . | Cytogenetics . | Cellularity, % . | BM content . | Cytogenetics . | ||
1 | 2 | 40-60 | Atypical megakaryocytes, 10%-15% plasma cells | Normal | 40-60 | Trilineage hematopoiesis, 8%-10% plasma cells | Normal |
2 | 0.2 | 50 | ↑Megakaryocytes, Dysplasia, ? clonal LGL | ND | 30 | ↓ Megakaryocytes, hemophagocytic macrophages | ND |
3 | 0.6 | 5-20 | Markedly hypocellular with trilineage hypoplasia | −Y | 60 | Normal marrow | Normal |
4 | 0.6 | 30-60 | ↓ Atypical megakaryocytes, focal ↑ blasts | +8 | 40-50 | Trilineage hematopoiesis | Normal |
5 | 1.0 | 50-60 | Atypical megakaryocytes, 10% myeloblasts | −6 | 10-60 | Few atypical megakaryocytes, < 5% blasts | Normal |
6 | 0.6 | 40-60 | Atypical megakaryocytes, mild dysplasia | −7 | 10-20 | Trilineage hypoplasia, no ↑ blasts | Normal |
MDS indicates myelodysplastic syndrome; ND, not done; and LGL, large granular lymphocyte.